RPS6KB1 and neoplasm: This phenomenon may be explained by the metformin-mediated activation of AMPK (dependently or independently of LKB1 expression), which attenuates anabolic processes, such as protein synthesis, through inhibition of ribosomal subunit P70S6K, thereby impairing the production of important proteins for tumor progression [12,36,37].